Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genenet Technology
Cambridge, England, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Genenet Technology has developed AI-powered gene circuit design platforms, CHO cell bioproduction technologies, and early-stage organoid-on-chip models. It is engaged in pre-clinical proprietary and partnered R&D; no clinical results reported yet.
- Therapeutic areas
- HematologyRare DiseasesCardiovascularOther
- Modalities
- Gene therapyCell therapyGenetic circuitOrganoid-based discovery platform
- Industry
- Non-Drug Biotech
02
Partnerships
Innovate UKBritish Office in TaipeiCPI (UK)Medicines Discovery Catapult (UK)ITRI Taiwan
Beyond the preview
Go deeper on Genenet Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genenet Technology.